<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="2-part\PMC6997034\results\search\funders\results.xml">
  <result pre="J2LeungNancy HLhttps://orcid.org/0000-0001-7314-840X2CowlingBenjamin J2ValkenburgSophie Ahttps://orcid.org/0000-0002-0768-992612sophiev@hku.hk[1], HKU�?Pasteur Research PoleSchool of Public HealthThe" exact="University of Hong Kong" post="Hong Kong[2], World Health Organization Collaborating Centre for Infectious"/>
  <result pre="PoleSchool of Public HealthThe University of Hong Kong Hong Kong[2]," exact="World Health Organization" post="Collaborating Centre for Infectious Disease Epidemiology and ControlSchool of"/>
  <result pre="Centre for Infectious Disease Epidemiology and ControlSchool of Public HealthThe" exact="University of Hong Kong" post="Hong Kong[3], Service d'Immunologie BiologiqueCentre Hospitalier Universitaire CochinFaculté de"/>
  <result pre="for Disease Control and PreventionIP001064�?02 General Research Fund of the" exact="University Grants Committee" post="of Hong Kong17113718 fig-count: table-count: page-count: word-count: Introduction Vaccination"/>
  <result pre="the 2017/2018 Northern Hemisphere formulation of either standard FluQuadri (S�?IIV," exact="Sanofi" post="Pasteur, Lyon, France) or one of three eIIVs, including"/>
  <result pre="A�?eIIV, Seqirus, Maidenhead, UK), high dose (FluZone high dose, H�?eIIV," exact="Sanofi" post="Pasteur) and recombinant HA (FluBlok, R�?eIIV, Sanofi Pasteur) (Table"/>
  <result pre="high dose, H�?eIIV, Sanofi Pasteur) and recombinant HA (FluBlok, R�?eIIV," exact="Sanofi" post="Pasteur) (Table 1).18 Sera were collected for baseline responses"/>
  <result pre="protocol was approved by the Institutional Review Board of the" exact="University of Hong Kong" post="(UW:16�?2014). Vaccination and infection of mice To assess eIIV"/>
  <result pre="the Use of Live Animals in Teaching and Research, The" exact="University of Hong Kong." post="Antibody quantification by enzyme�?linked immunosorbent assay (ELISA) To assess"/>
  <result pre="serum samples were derived from a study supported by the" exact="Centers for Disease Control and Prevention" post="(Cooperative Agreement Number, IP001064�?02). Mouse studies were supported by"/>
  <result pre="grant (contract HHSN272201400006C) and the General Research Fund of the" exact="University Grants Committee" post="of Hong Kong (17113718). This paper content is solely"/>
  <result pre="and does not necessarily represent the official views of the" exact="Centers for Disease Control and Prevention" post="or the Department of Health and Human Services. Conflict"/>
  <result pre="of the Centers for Disease Control and Prevention or the" exact="Department of Health" post="and Human Services. Conflict of interest BJC has received"/>
  <result pre="Human Services. Conflict of interest BJC has received honoraria from" exact="Sanofi" post="and Roche for advisory committees. The authors report no"/>
  <result pre="Conflict of interest BJC has received honoraria from Sanofi and" exact="Roche" post="for advisory committees. The authors report no other potential"/>
  <result pre="StemmyEJet alA universal influenza vaccine: the strategic plan for the" exact="National Institute of Allergy and Infectious Diseases." post="J Infect Dis2018; 218: 347–354.29506129 28KumarA, MeldgaardTS, BertholetS. Novel"/>
  <result pre="Administration . 2019 seasonal influenza vaccines; https://www.tga.gov.au/alert/2019-seasonal-influenza-vaccines. Therapeutic Goods Administration" exact="Department of Health" post="Australian Government; 2019 [e�?pub ahead of print 31 October"/>
 </snippets>
</snippetsTree>
